The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus
Authors
Keywords
-
Journal
Metabolites
Volume 11, Issue 12, Pages 807
Publisher
MDPI AG
Online
2021-11-30
DOI
10.3390/metabo11120807
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liraglutide Increases the Catabolism of Apolipoprotein B100–Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression
- (2021) Bruno Vergès et al. DIABETES CARE
- Low-density lipoprotein cholesterol is associated with insulin secretion
- (2021) Corinna Dannecker et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis
- (2021) Hang-Long Li et al. Cardiovascular Diabetology
- Recent Molecular Mechanisms and Beneficial Effects of Phytochemicals and Plant-Based Whole Foods in Reducing LDL-C and Preventing Cardiovascular Disease
- (2021) Salman Ul Islam et al. Antioxidants
- Heparin binding triggers human VLDL remodeling by circulating lipoprotein lipase: Relevance to VLDL functionality in health and disease
- (2021) Shobini Jayaraman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
- (2020) Jan Borén et al. EUROPEAN HEART JOURNAL
- Electronegative LDL Promotes Inflammation and Triglyceride Accumulation in Macrophages
- (2020) Núria Puig et al. Cells
- Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study
- (2020) Jing-Lu Jin et al. Cardiovascular Diabetology
- A survey on intensity of statin therapy among diabetes mellitus patients in secondary care practice
- (2020) K. Indira Adiga et al. International Journal of Diabetes in Developing Countries
- NADPH Oxidases and Their Role in Atherosclerosis
- (2020) Anastasia V. Poznyak et al. Biomedicines
- Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes
- (2020) Marja-Riitta Taskinen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect
- (2020) Dragana Nikolic et al. Diabetes Therapy
- Endothelial Dysfunction in Diabetes Is Aggravated by Glycated Lipoproteins; Novel Molecular Therapies
- (2020) Laura Toma et al. Biomedicines
- Future perspectives of the pharmacological management of diabetic dyslipidemia
- (2019) Angelo Maria Patti et al. Expert Review of Clinical Pharmacology
- Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells
- (2019) Cécile L. Bandet et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice
- (2019) Susanne Schuster et al. Scientific Reports
- GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms
- (2018) Manfredi Rizzo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition
- (2018) Debapriya Basu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Association between insulin resistance and the development of cardiovascular disease
- (2018) Valeska Ormazabal et al. Cardiovascular Diabetology
- Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study
- (2018) Ian J. Neeland et al. DIABETOLOGIA
- Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: A US-based cross-sectional observational study using electronic health records
- (2018) QiPing Feng et al. PLOS MEDICINE
- Oxidative Modification of LDL by Various Physicochemical Techniques: Its Probable Role in Diabetes Coupled with CVDs
- (2018) Sultan Alouffi et al. Biomed Research International
- Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why
- (2018) Marco Mol et al. Redox Biology
- Apolipoprotein status in type 2 diabetes mellitus and its complications
- (2017) Puhong Zhang et al. Molecular Medicine Reports
- Association between reductions in low-density lipoprotein cholesterol with statin therapy and the risk of new-onset diabetes: a meta-analysis
- (2017) Shaohua Wang et al. Scientific Reports
- Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans
- (2017) Leonore Wigger et al. Cell Reports
- PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
- (2017) Amand F Schmidt et al. Lancet Diabetes & Endocrinology
- Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus
- (2017) Robert P. Giugliano et al. CIRCULATION
- Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia
- (2017) Elisenda Climent et al. Scientific Reports
- Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus
- (2016) Nobuya Inagaki et al. Cardiovascular Diabetology
- Approach to Statin Use in 2016: an Update
- (2016) P. Elliott Miller et al. Current Atherosclerosis Reports
- Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis
- (2016) F. Zaccardi et al. DIABETES OBESITY & METABOLISM
- A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality
- (2016) Rishi K. Wadhera et al. Journal of Clinical Lipidology
- Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
- (2016) Brian A. Ference et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Associations of Circulating Oxidized LDL and Conventional Biomarkers of Cardiovascular Disease in a Cross-Sectional Study of the Navajo Population
- (2016) Molly E. Harmon et al. PLoS One
- Diabetes Dyslipidemia
- (2016) Jonathan D. Schofield et al. Diabetes Therapy
- Diabetes Dyslipidemia
- (2016) Jonathan D. Schofield et al. Diabetes Therapy
- Using Genetic Variants to Assess the Relationship Between Circulating Lipids and Type 2 Diabetes
- (2015) Tove Fall et al. DIABETES
- Durability and tolerability of dapagliflozin over 52 weeks as add-on to metformin and sulphonylurea in type 2 diabetes
- (2015) S. Matthaei et al. DIABETES OBESITY & METABOLISM
- Long-term efficacy and safety of canagliflozin over 104 weeks in patients aged 55-80 years with type 2 diabetes
- (2015) B. Bode et al. DIABETES OBESITY & METABOLISM
- Low-density-lipoprotein cholesterol concentrations and risk of incident diabetes: epidemiological and genetic insights from the Framingham Heart Study
- (2015) Charlotte Andersson et al. DIABETOLOGIA
- Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus
- (2015) Joost Besseling et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hepatic Lipase: a Comprehensive View of its Role on Plasma Lipid and Lipoprotein Metabolism
- (2015) Junji Kobayashi et al. Journal of Atherosclerosis and Thrombosis
- HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
- (2015) Daniel I Swerdlow et al. LANCET
- Oxidized LDL and NO synthesis—Biomarkers of endothelial dysfunction and ageing
- (2015) Daniela Gradinaru et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety Profile of Subjects Treated to Very Low Low-Density Lipoprotein Cholesterol Levels (
- (2014) Brendan M. Everett et al. AMERICAN JOURNAL OF CARDIOLOGY
- Thiazolidinediones and the Promise of Insulin Sensitization in Type 2 Diabetes
- (2014) Raymond E. Soccio et al. Cell Metabolism
- Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes
- (2014) Dongxu Fu et al. JOURNAL OF LIPID RESEARCH
- Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet – the RESOLVE trial
- (2014) Frédéric Dutheil et al. Lipids in Health and Disease
- Lower Intensified Target LDL-c Level of Statin Therapy Results in a Higher Risk of Incident Diabetes: A Meta-Analysis
- (2014) Rongrong Cai et al. PLoS One
- Oxidized Low-Density Lipoprotein Suppresses Expression of Prostaglandin E Receptor Subtype EP3 in Human THP-1 Macrophages
- (2014) Xuxia Sui et al. PLoS One
- Oxidized low density lipoprotein and total antioxidant capacity in type-2 diabetic and impaired glucose tolerance Saudi men
- (2014) Essam Eldin Nour Eldin et al. Diabetology & Metabolic Syndrome
- Endothelial dysfunction — A major mediator of diabetic vascular disease
- (2013) Cristina M. Sena et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes
- (2013) Jose Sánchez-Quesada et al. Cardiovascular Diabetology
- Very Low Density Lipoprotein Receptor (VLDLR) Expression Is a Determinant Factor in Adipose Tissue Inflammation and Adipocyte-Macrophage Interaction
- (2013) Andrew Nguyen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small, Dense LDL Particles Predict Changes in Intima Media Thickness and Insulin Resistance in Men with Type 2 Diabetes and Prediabetes – A Prospective Cohort Study
- (2013) Philipp A. Gerber et al. PLoS One
- Lipoproteínas modificadas como marcadores de riesgo cardiovascular en la diabetes mellitus
- (2013) José Luis Sánchez-Quesada et al. Endocrinologia y Nutricion
- Effect of Improving Glycemic Control in Patients With Type 2 Diabetes Mellitus on Low-Density Lipoprotein Size, Electronegative Low-Density Lipoprotein and Lipoprotein-Associated Phospholipase A2 Distribution
- (2012) José L. Sánchez-Quesada et al. AMERICAN JOURNAL OF CARDIOLOGY
- d-Glucose modulates intestinal Niemann-Pick C1-like 1 (NPC1L1) gene expression via transcriptional regulation
- (2012) Pooja Malhotra et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Statins are diabetogenic – Myth or reality?
- (2012) Naveed Sattar et al. ATHEROSCLEROSIS SUPPLEMENTS
- Ceramides Contained in LDL Are Elevated in Type 2 Diabetes and Promote Inflammation and Skeletal Muscle Insulin Resistance
- (2012) J. Boon et al. DIABETES
- Mechanisms of modified LDL-induced pericyte loss and retinal injury in diabetic retinopathy
- (2012) D. Fu et al. DIABETOLOGIA
- Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy
- (2012) David D. Waters et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anti-oxidant and anti-inflammatory mechanisms of amlodipine action to improve endothelial cell dysfunction induced by irreversibly glycated LDL
- (2011) Laura Toma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pathways of cholesterol oxidation via non-enzymatic mechanisms
- (2011) Luigi Iuliano CHEMISTRY AND PHYSICS OF LIPIDS
- Are statins diabetogenic?
- (2011) Uchechukwu K Sampson et al. CURRENT OPINION IN CARDIOLOGY
- Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A review of their efficacy and tolerability
- (2011) A. J. Garber DIABETES CARE
- Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials
- (2011) L. A. Leiter et al. DIABETES OBESITY & METABOLISM
- Role for inducible cAMP early repressor in promoting pancreatic beta cell dysfunction evoked by oxidative stress in human and rat islets
- (2011) D. Favre et al. DIABETOLOGIA
- Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy
- (2011) David Preiss JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mechanisms of LDL oxidation
- (2010) Hiroshi Yoshida et al. CLINICA CHIMICA ACTA
- Increased Glycation and Oxidative Damage to Apolipoprotein B100 of LDL Cholesterol in Patients With Type 2 Diabetes and Effect of Metformin
- (2010) N. Rabbani et al. DIABETES
- Should we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with type 2 diabetes?
- (2010) M. Rizzo et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy
- (2010) Martina Krüger et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Increased Lipid Peroxidation in LDL from Type-2 Diabetic Patients
- (2010) Romain Colas et al. LIPIDS
- Oxidized Low-Density Lipoprotein Inhibits Nitric Oxide-Mediated Coronary Arteriolar Dilation by Up-regulating Endothelial Arginase I
- (2010) WEI WANG et al. MICROCIRCULATION
- Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma
- (2009) Constantinos C. Tellis et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus
- (2009) Brian G. Drew et al. CIRCULATION
- Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study
- (2009) Omer T. Njajou et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Lipid modification in type 2 diabetes: the role of LDL and HDL
- (2009) Bruno Vergès FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Dyslipidemia in type 2 diabetes mellitus
- (2009) Arshag D Mooradian Nature Reviews Endocrinology
- Modulation of intestinal cholesterol absorption by high glucose levels: impact on cholesterol transporters, regulatory enzymes, and transcription factors
- (2008) Z. Ravid et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells
- (2008) Ling Li et al. ATHEROSCLEROSIS
- Glycation as an atherogenic modification of LDL
- (2008) Nahla Younis et al. CURRENT OPINION IN LIPIDOLOGY
- Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance
- (2008) J. M. Haus et al. DIABETES
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2008) D. M. Nathan et al. DIABETES CARE
- Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes
- (2008) B. Vergès et al. DIABETOLOGIA
- Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes
- (2008) Kaspar Berneis et al. EXPERT OPINION ON PHARMACOTHERAPY
- Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry
- (2008) Philipp Wiesner et al. JOURNAL OF LIPID RESEARCH
- Pharmacological Differences of Glitazones
- (2008) Ulrich Kintscher JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
- (2008) LANCET
- Structural basis for the activation of PPARγ by oxidized fatty acids
- (2008) Toshimasa Itoh et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now